printemailclick to share buttonfacebooktwitterlinkedin
Funding for Systemic Treatment Clinical Trials
 

The funding stream to support patients on clinical trials may differ depending on the trial in which the patient is participating.

When a publicly funded cancer drug is used within or subsequent to a clinical trial in accordance with Provincial Drug Reimbursement Programs or Ontario Public Drug Programs drug funding policies, funding will be provided by those programs. To find out more about reimbursement of publicly funded cancer drugs through PDRP and/or OPDP, please refer to the revised Policy 3.0 and the FAQs.

For older or inexpensive cancer drugs, the cost of the drugs, their preparation, delivery, and related clinical care for patients on clinical trials is provided through the Systemic Treatment-Quality Based Program (ST-QBP). To find out more about the reimbursement provided through the ST-QBP, please refer to the program’s principles that guide the funding of clinical trials.

For the purpose of funding through the ST-QBP, a clinical trial is an intervention to evaluate a drug or biologic agent for its anti-cancer activity, which has undergone institutional (peer) review and received ethics approval at the institutional or provincial level. Trials meeting this definition will receive funding for the cost of evidence-informed drugs that are not funded through PDRP or OPDP (i.e., older and inexpensive drugs) and their administration costs. Clinical trials that do not evaluate the anti-cancer impact of a new drug or regimen but are designed to assess only a diagnostic, symptom management or resource utilization question, for example, would not be considered for funding through the ST-QBP and therefore categorized as “not aligned”. However, if patients receive an evidence-informed standard of care within the context of a “non-aligned” trial, they will still receive facility funding for the evidence-informed treatment and its administration.

Last modified: Mon, Dec 12, 2016
cancer care ontario | action cancer ontario   620 University Avenue Toronto Ontario, Canada M5G 2L7   Phone: 416.971.9800 Fax: 416.971.6888

Please help improve the quality of our website by answering 10 brief questions in our online survey. Would you like to participate?

YesNo